Concepedia

Publication | Open Access

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

DOIFull Paper Access

226

Citations

17

References

2021

Year

Luis Rivera, Shibadas Biswal, Xavier Sáez‐Llorens, Humberto Reynales, Eduardo López‐Medina, Charissa Borja-Tabora, Lulu Bravo, Chukiat Sirivichayakul, Pope Kosalaraksa, Luis Martinez Vargas,
Clinical Infectious Diseases

Abstract

TAK-003 was efficacious against symptomatic dengue over 3 years. Efficacy declined over time but remained robust against hospitalized dengue. A booster dose evaluation is planned.

References

YearCitations

Page 1